ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	16/89	191/7206	1.02561043433e-09
ko04380	Osteoclast differentiation	11/89	134/7206	6.4717142932e-07
ko05166	HTLV-I infection	15/89	292/7206	2.31154157958e-06
ko04933	AGE-RAGE signaling pathway in diabetic complications	9/89	135/7206	3.89112190777e-05
ko04610	Complement and coagulation cascades	7/89	79/7206	4.87051284711e-05
ko05230	Central carbon metabolism in cancer	7/89	81/7206	5.72698898627e-05
ko05212	Pancreatic cancer	7/89	83/7206	6.7031015004e-05
ko04151	PI3K-Akt signaling pathway	15/89	390/7206	7.33672859881e-05
ko04672	Intestinal immune network for IgA production	5/89	37/7206	8.19267097398e-05
ko05200	Pathways in cancer	17/89	492/7206	8.76187946918e-05
ko04621	NOD-like receptor signaling pathway	9/89	157/7206	0.000126144546227
ko04072	Phospholipase D signaling pathway	10/89	197/7206	0.000144130913114
ko04650	Natural killer cell mediated cytotoxicity	7/89	97/7206	0.000180369217098
ko04630	Jak-STAT signaling pathway	8/89	132/7206	0.000208356175578
ko05321	Inflammatory bowel disease (IBD)	5/89	56/7206	0.000597123786172
ko04658	Th1 and Th2 cell differentiation	6/89	96/7206	0.00114041345558
ko05231	Choline metabolism in cancer	7/89	134/7206	0.0012751027199
ko04659	Th17 cell differentiation	6/89	106/7206	0.00190214904779
ko04510	Focal adhesion	9/89	240/7206	0.00270759499297
ko05214	Glioma	5/89	79/7206	0.0028214533197
ko04144	Endocytosis	11/89	342/7206	0.00308334329469
ko05162	Measles	6/89	120/7206	0.00355037507518
ko00590	Arachidonic acid metabolism	4/89	52/7206	0.00374655960195
ko04750	Inflammatory mediator regulation of TRP channels	6/89	122/7206	0.00385260555313
ko05218	Melanoma	5/89	85/7206	0.00387594197221
ko05220	Chronic myeloid leukemia	5/89	85/7206	0.00387594197221
ko04066	HIF-1 signaling pathway	6/89	123/7206	0.00401070063191
ko05210	Colorectal cancer	5/89	86/7206	0.00407580503512
ko04662	B cell receptor signaling pathway	5/89	88/7206	0.00449750479838
ko05418	Fluid shear stress and atherosclerosis	7/89	173/7206	0.0053691634882
ko04218	Cellular senescence	7/89	177/7206	0.00607328098115
ko04217	Necroptosis	7/89	178/7206	0.00625964473575
ko04064	NF-kappa B signaling pathway	5/89	96/7206	0.00649827415859
ko04015	Rap1 signaling pathway	9/89	278/7206	0.00708755698007
ko05146	Amoebiasis	5/89	99/7206	0.00738814411371
ko04620	Toll-like receptor signaling pathway	5/89	100/7206	0.00770278994927
ko05202	Transcriptional misregulation in cancer	7/89	188/7206	0.00836676310415
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/89	191/7206	0.00909056868149
ko01521	EGFR tyrosine kinase inhibitor resistance	5/89	106/7206	0.00978923195555
ko04670	Leukocyte transendothelial migration	6/89	151/7206	0.0106886779162
ko05215	Prostate cancer	5/89	111/7206	0.0118021061126
ko05140	Leishmaniasis	4/89	75/7206	0.0135780548257
ko04664	Fc epsilon RI signaling pathway	4/89	77/7206	0.0148400510609
ko04611	Platelet activation	6/89	163/7206	0.0151596732091
ko04512	ECM-receptor interaction	4/89	79/7206	0.0161740558296
ko04068	FoxO signaling pathway	6/89	167/7206	0.0169024547906
ko04024	cAMP signaling pathway	8/89	279/7206	0.021449165663
ko04014	Ras signaling pathway	8/89	279/7206	0.021449165663
ko05206	MicroRNAs in cancer	6/89	177/7206	0.0218558211163
ko05142	Chagas disease (American trypanosomiasis)	5/89	130/7206	0.0219902810939
ko05323	Rheumatoid arthritis	4/89	89/7206	0.0239633829754
ko05222	Small cell lung cancer	4/89	89/7206	0.0239633829754
ko04974	Protein digestion and absorption	4/89	96/7206	0.0305675384165
ko05211	Renal cell carcinoma	4/89	96/7206	0.0305675384165
ko05160	Hepatitis C	5/89	153/7206	0.0403996276705
ko05213	Endometrial cancer	3/89	62/7206	0.0408532521981
ko05169	Epstein-Barr virus infection	6/89	206/7206	0.0415314990807
ko04810	Regulation of actin cytoskeleton	7/89	264/7206	0.0440906575438
ko04020	Calcium signaling pathway	7/89	265/7206	0.0448462710218
ko05223	Non-small cell lung cancer	3/89	66/7206	0.0477392411548